● TIER 3 — Information onlyGRADE B (one placebo RCT)Nootropic / neuro peptides
Mexidol (emoxypine succinate)
Origin: Russia (Pharmasoft). Citations verified: yes. 1 human study record(s) in the FitClinicMD studies database.
GOALS · Cognition
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Mechanism
3-hydroxypyridine antioxidant (non-peptide).
Human evidence · 1
Stakhovskaya LV et al. EPICA. Zh Nevrol Psikhiatr 2017.
Reference only. This page summarizes publicly available regulatory and research information about Mexidol (emoxypine succinate). It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.